No profile data available.
Fractyl Health, Inc. (GUTS) is a healthcare company in the targeted healthcare equipment industry, based in Burlington, United States, with about 100 full-time employees.
It reported revenue of $0 for fiscal year 2025, down 100.0% from fiscal year 2024, and net income of -$140.95 million. Its market capitalization was $58.63 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. It develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans.
Fractyl Health reported $0 in revenue for fiscal year 2025, down 100.0% from $93,000 in fiscal year 2024.
$58.63 million as of October 9, 2026.
Listed companies of a similar size in the same industry (targeted healthcare equipment) include Microbot Medical Inc. (MBOT), Daxor Corporation (DXR), Medinotec Inc. (MDNC), Talphera, Inc. (TLPH).